Telerx Marketing Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
- Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – GlobalData’s summarization of the company’s business strategy. - SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Telerx Marketing Inc. (Telerx), a subsidiary of Merck & Co., Inc., is a business process outsourcing company that operates as a provider of outsourced customer care services and solutions. The company manages inbound call center services, customer experience and outcomes, and customer service outsourcing. It offers multi-channel engagement solutions for consumers, healthcare professionals, patients and enterprise personnel through a network of global contact centers. Telerx provides its services to life sciences and consumer goods companies. It offers a wide range of services related to innovation and regulatory compliance, and support services to protect their brands by maximizing productivity and cost efficiencies. The company has offices in Pennsylvania, Texas, North Carolina, New Jersey, India, Bulgaria and China. Telerx is headquartered in King of Prussia, Pennsylvania, the US.
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs. - Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy. - Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company. - Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
43 pages •
By Euromonitor International
• May 2018
Schwarz Beteiligungs GmbH continues to thrive, although its 2017 launch in the US (its first non-European market) has been bumpier than expected. While demand for its low prices remains central to its strategy, the company is also nudging up the quality of its offer, to capitalise on middle-class consumers and make its Lidl brand a credible...
Chondrosarcoma - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Chondrosarcoma - Pipeline Review, H1 2018, provides an overview of the Chondrosarcoma (Oncology) pipeline landscape. Chondrosarcoma is a malignant cancer whose...
H+ Transporting Two Sector ATPase (F1F0 ATP Synthase or ATP Synthase or Mitochondrial ATPase or Bacterial Ca2+/Mg2+ ATPase or EC 22.214.171.124) - Pipeline Review, H1 2018 Summary According to the recently published report ’H+ Transporting Two Sector ATPase - Pipeline Review, H1 2018’; H+ Transporting...
Tyrosine Protein Kinase Fyn (Proto Oncogene Syn or Proto Oncogene c Fyn or Src Like Kinase or p59 Fyn or FYN or EC 126.96.36.199) - Pipeline Review, H1 2018 Summary Tyrosine Protein Kinase Fyn (Proto Oncogene Syn or Proto Oncogene c Fyn or Src Like Kinase or p59 Fyn or FYN or EC 188.8.131.52) pipeline Target...